A detailed history of North Star Investment Management Corp. transactions in Biogen Inc. stock. As of the latest transaction made, North Star Investment Management Corp. holds 5,622 shares of BIIB stock, worth $977,047. This represents 0.08% of its overall portfolio holdings.

Number of Shares
5,622
Previous 5,634 0.21%
Holding current value
$977,047
Previous $1.31 Million 16.62%
% of portfolio
0.08%
Previous 0.1%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$189.07 - $236.8 $2,268 - $2,841
-12 Reduced 0.21%
5,622 $1.09 Million
Q4 2023

Jan 10, 2024

SELL
$222.59 - $267.94 $1,112 - $1,339
-5 Reduced 0.09%
5,634 $1.46 Million
Q3 2023

Nov 06, 2023

SELL
$253.3 - $285.89 $5,066 - $5,717
-20 Reduced 0.35%
5,639 $1.45 Million
Q1 2023

Apr 27, 2023

BUY
$256.56 - $292.34 $1.42 Million - $1.62 Million
5,551 Added 5139.81%
5,659 $1.57 Million
Q4 2022

Jan 11, 2023

SELL
$252.44 - $306.72 $13,379 - $16,256
-53 Reduced 32.92%
108 $0
Q3 2022

Nov 02, 2022

SELL
$194.69 - $268.46 $6,230 - $8,590
-32 Reduced 16.58%
161 $43,000
Q1 2022

May 03, 2022

SELL
$193.77 - $244.14 $37,203 - $46,874
-192 Reduced 49.87%
193 $41,000
Q4 2021

Feb 07, 2022

BUY
$223.92 - $287.77 $44,336 - $56,978
198 Added 105.88%
385 $92,000
Q3 2021

Oct 20, 2021

SELL
$282.99 - $369.05 $2,546 - $3,321
-9 Reduced 4.59%
187 $53,000
Q2 2021

Jul 13, 2021

BUY
$259.0 - $414.71 $6,216 - $9,953
24 Added 13.95%
196 $68,000
Q1 2021

Apr 19, 2021

SELL
$242.95 - $284.63 $101,067 - $118,406
-416 Reduced 70.75%
172 $48,000
Q4 2020

Jan 12, 2021

BUY
$236.26 - $355.63 $15,120 - $22,760
64 Added 12.21%
588 $144,000
Q3 2020

Oct 13, 2020

BUY
$264.77 - $305.71 $137,680 - $158,969
520 Added 13000.0%
524 $149,000
Q1 2020

Apr 23, 2020

BUY
$268.85 - $341.04 $1,075 - $1,364
4 New
4 $1,000
Q3 2019

Oct 03, 2019

SELL
$217.44 - $243.88 $500,112 - $560,924
-2,300 Closed
0 $0
Q2 2019

Jul 15, 2019

BUY
$219.29 - $241.72 $113,372 - $124,969
517 Added 29.0%
2,300 $538,000
Q1 2019

Apr 10, 2019

BUY
$216.71 - $338.96 $386,393 - $604,365
1,783 New
1,783 $421,000
Q3 2018

Oct 11, 2018

SELL
$293.51 - $383.83 $10,859 - $14,201
-37 Closed
0 $0
Q1 2018

Apr 13, 2018

SELL
$260.13 - $367.91 $1,560 - $2,207
-6 Reduced 13.95%
37 $10,000
Q3 2017

Oct 06, 2017

BUY
$281.15 - $329.69 $12,089 - $14,176
43
43 $13,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track North Star Investment Management Corp. Portfolio

Follow North Star Investment Management Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.